4.7 Review

A comprehensive review on acridone based derivatives as future anti-cancer agents and their structure activity relationships

期刊

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2022.114527

关键词

Acridone derivatives; Biological targets; DNA topoisomerase; Telomerase; P-gp; SAR

资金

  1. DHR Project - Department of Health Research, Government of India [V. 25011/547-HRD/2016-HR]

向作者/读者索取更多资源

The clinical efficacy of existing anticancer drugs has been reduced due to drug resistance and severe side-effects. Therefore, the development of new anti-cancer drugs with minimal adverse effects is always needed. Acridone is a promising heterocycle that has gained attention for its ability to act on various molecular targets, overcome drug resistance, and intercalate DNA in cancer cells. Some acridone derivatives have already entered clinical studies and have shown great potential in cancer therapeutics and imaging.
The development of drug resistance and severe side-effects has reduced the clinical efficacy of the existing anticancer drugs available in the market. Thus, there is always a constant need to develop newer anti-cancer drugs with minimal adverse effects. Researchers all over the world have been focusing on various alternative strategies to discover novel, potent, and target specific molecules for cancer therapy. In this direction, several heterocyclic compounds are being explored but amongst them one promising heterocycle is acridone which has attracted the attention of medicinal chemists and gained huge biological importance as acridones are found to act on different therapeutically proven molecular targets, overcome ABC transporters mediated drug resistance and DNA intercalation in cancer cells. Some of these acridone derivatives have reached clinical studies as these heterocycles have shown huge potential in cancer therapeutics and imaging. Here, the authors have attempted to compile and make some recommendations of acridone based derivatives concerning their cancer biological targets and in vitro-cytotoxicity based on drug design and novelty to increase their therapeutic potential. This review also provides some important insights on the design, receptor targeting and future directions for the development of acridones as possible clinically effective anti-cancer agents.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据